(NasdaqGM:GECC), Board Maintains $0.37 Per Share Distribution and Announces $10 Million Share Repurchase Authorization GECC Strengthened its Balance Sheet Raising $27 Million of Equity and Refinancing Highest Cost Debt NAV Decline From $12.10 to $10.01 Per Share Primarily Due to Losses on First Brands; NII Lower As Anticipated Due to Uneven CLO JV Distributions and […]
(NASDAQ:AMD), SANTA CLARA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — AMD (NASDAQ:AMD) today announced financial results for the third quarter of 2025. Third quarter revenue was a record $9.2 billion, gross margin was 52%, operating income was $1.3 billion, net income was $1.2 billion and diluted earnings per share was $0.75. On a non-GAAP(*) basis,
(NASDAQ:FTEK), WARRENVILLE, Ill., Nov. 04, 2025 (GLOBE NEWSWIRE) — Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today reported financial results for the third quarter ended September 30, 2025. “We operated profitably in the third quarter, expanded
(NYSE:NVGS), LONDON, Nov. 04, 2025 (GLOBE NEWSWIRE) — Third Quarter Financial Highlights On November 4, 2025, the Board of Directors of Navigator Holdings Ltd., (NYSE: NVGS) (“Navigator Holdings”, “Navigator Gas”, “our”, “we”, “us” or the “Company”) approved a revision to the Company's existing capital return policy first announced in May 2023 (the “Revised Capital Return
(NASDAQ:ANAB), Announced intent to separate biopharma operations from substantial royalty assets by YE 2026 Phase 2 top-line data through Week 12 for rosnilimab, a pathogenic T cell depleter, in ulcerative colitis on track for Nov./Dec. 2025 Phase 2b data for rosnilimab in rheumatoid arthritis featured as late-breaking oral presentation at ACR Convergence 2025 Phase 1b
(NASDAQ:ANAB), SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences: TD Cowen Immunology
(NYSE:BKKT), NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Bakkt Holdings, Inc. (“Bakkt” or the “Company”) (NYSE:BKKT) announced today announced that it has completed its previously disclosed reorganization, eliminating its umbrella partnership-C corporation (“Up-C”) structure and transitioning to a single class of common stock. The completion of this restructuring considerably simplifies Bakkt's capital structure and
(NYSE:HIW), RALEIGH, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) — Highwoods Properties, Inc. (NYSE: HIW) (the “Company”) announced today that Highwoods Realty Limited Partnership, the operating partnership through which the Company conducts its operations, has priced a $350 million offering of 5.350% unsecured notes under its existing shelf registration statement. The notes are due January 15,
(NYSE:PARR), HOUSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the quarter ended September 30, 2025. Net Income of $262.6 million, or $5.16 per diluted share Adjusted Net Income of $302.6 million, or $5.95 per diluted share Adjusted EBITDA of
(NYSE:HPQ), PALO ALTO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — HP Inc. (NYSE: HPQ) will present a live audio webcast of a conference call to review financial results for the fourth fiscal quarter and fiscal year ended October 31, 2025 on Tuesday, Nov 25, 2025 at 5:00 p.m. ET / 2:00 p.m. PT. The webcast